Board of Directors
Dave Lemus
CFO, MorphoSys AG
Mr. Lemus is the Chief Financial Officer of MorphoSys AG, one of the world’s leading biotechnology companies focusing on fully human antibodies. He joined the MorphoSys in 1998, and took the company public in 1999. Mr. Lemus has an M.B.A. from the MIT Sloan School of Management and is also a Certified Public Accountant in the US.
Mr. Lemus joined MorphoSys in February 1998 from F. Hoffmann-La Roche´s international division where he served as Controller and Operations Manager of 90 pharmaceutical markets. Prior to this position he was Treasurer of Lindt & Sprüngli in Zurich, Switzerland and worked in treasury management at Electrolux AB.
The value that Mr. Lemus brings to Axela includes a broad knowledge of the Antibody market, relationships with large pharmaceutical companies, EU insight and awareness, financial acumen and capital market expertise.